相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Case Report: First Long-Term Treatment With Burosumab in a Patient With Cutaneous-Skeletal Hypophosphatemia Syndrome
Lea Maria Merz et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
Burosumab for the Treatment of Tumor-Induced Osteomalacia
Suzanne M. Jan de Beur et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
DIAGNOSIS OF ENDOCRINE DISEASE Mosaic disorders of FGF23 excess: Fibrous dysplasia/McCune-Albright syndrome and cutaneous skeletal hypophosphatemia syndrome
Luis F. de Castro et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2020)
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
Erik A. Imel et al.
LANCET (2019)
Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2019)
Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial
Michael P. Whyte et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Epidermal nevus syndromes: New insights into whorls and swirls
Sarah Asch et al.
PEDIATRIC DERMATOLOGY (2018)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Karl L. Insogna et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Thomas O. Carpenter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Cutaneous skeletal hypophosphatemia syndrome (CSHS) is a multilineage somatic mosaic RASopathy
Young H. Lim et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Cutaneous skeletal hypophosphatemia syndrome: clinical spectrum, natural history, and treatment
D. Ovejero et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia
Young H. Lim et al.
HUMAN MOLECULAR GENETICS (2014)
REGULATION AND FUNCTION OF THE FGF23/KLOTHO ENDOCRINE PATHWAYS
Aline Martin et al.
PHYSIOLOGICAL REVIEWS (2012)
Treatment of X-Linked Hypophosphatemia with Calcitriol and Phosphate Increases Circulating Fibroblast Growth Factor 23 Concentrations
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The FgF23-Klotho axis: endocrine regulation of phosphate homeostasis
M. Shawkat Razzaque
NATURE REVIEWS ENDOCRINOLOGY (2009)
Assessment of clinical relevant fatigue level in cancer
Yoon Jung Chang et al.
SUPPORTIVE CARE IN CANCER (2007)
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer pain
S Keller et al.
CLINICAL JOURNAL OF PAIN (2004)
Normative data for iliac bone histomorphometry in growing children
FH Glorieux et al.
BONE (2000)
分享论文
